Neogenomics Inc (NEO)
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Last price
- $16.84
- As of
Kresmion compiles this page from NEO's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
NEOGENOMICS INC (NEO): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-10-28.
See the full NEO dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for NEO on one page. Preview it with sample data, then open it live with a free account.
Preview the NEO dossierActive events for NEO
- mediumEarnings above estimates
Q3-2026: Beat consensus by 27.5%, EPS $0.07 vs $0.0549 estimate
- high13F: funds reduced
3 tracked funds reduced NEO this 2026Q2, institutional consensus
- high13F: large reduction
CITADEL ADVISORS LLC cut 85% of NEO (2026Q2)
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 77% of NEO (2026Q2)
- high13F: large reduction
TWO SIGMA INVESTMENTS, LP cut 77% of NEO (2026Q2)
FREE, NO ACCOUNT
Every event on NEO, as it fires
You are seeing 5 of 15 events recorded on NEO since 2026-05-31.
The five above landed across 2 days. The other 10 were recorded on 3 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
NEO positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| MILLENNIUM MANAGEMENT LLC FundCUSIP 64049M209 · 2026Q2 | $44.9M | 0.03% |
| D. E. Shaw & Co., Inc. FundCUSIP 64049M209 · 2026Q2 | $32M | 0.02% |
| MILLENNIUM MANAGEMENT LLC FundCUSIP 64049MAB6 · 2026Q2 | $2.4M | 0.00% |
| TWO SIGMA INVESTMENTS, LP FundCUSIP 64049M209 · 2026Q2 | $576K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, NEO
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
More data on NEO
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in NEO on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on NEO in the last 180 days.
Upstream: SEC EDGAR filings for NEO
Kresmion, "NEOGENOMICS INC (NEO) institutional holdings and SEC filings", data as of 2026-10-31, https://kresmion.com/research/NEO. Upstream data: SEC EDGAR filings for NEO.
Link to this data (HTML):
<a href="https://kresmion.com/research/NEO">NEOGENOMICS INC (NEO) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow NEO on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to NEO for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.